Wong A - Search Results

1

Epidemiology, Treatment Patterns and Survival in Canadian Patients With Chronic Hepatitis B-Related Hepatocellular Carcinoma.

Sachar Y, Congly SE, Burak KW, Manko A, Ko HH, Ramji A, Rahman HS, Talia J, Jeyaparan J, Wong DW, Fung S, Cooper C, Kelly EM, Ma MM, Bailey R, Minuk G, Wong A, Doucette K, Elkashab M, Sebastiani G, Wong P, Coffin CS, Brahmania M. Sachar Y, et al. Among authors: wong p, wong a, wong dw. J Viral Hepat. 2024 Nov;31(11):739-745. doi: 10.1111/jvh.13989. Epub 2024 Aug 16. J Viral Hepat. 2024. PMID: 39148449

2

Real-world impact of direct acting antiviral therapy on health-related quality of life in HIV/Hepatitis C co-infected individuals.

Saeed S, Moodie EEM, Strumpf E, Gill J, Wong A, Cooper C, Walmsley S, Hull M, Martel-Laferriere V, Klein MB; Canadian Co-Infection Cohort Study Investigators. Saeed S, et al. Among authors: wong a. J Viral Hepat. 2018 Dec;25(12):1507-1514. doi: 10.1111/jvh.12985. Epub 2018 Sep 27. J Viral Hepat. 2018. PMID: 30141236

3

Daclatasvir and sofosbuvir with ribavirin for 24 weeks in chronic hepatitis C genotype-3-infected patients with cirrhosis: a Phase III study (ALLY-3C).

Poordad F, Shiffman ML, Ghesquiere W, Wong A, Huhn GD, Wong F, Ramji A, Shafran SD, McPhee F, Yang R, Noviello S, Linaberry M; ALLY-3C study team. Poordad F, et al. Among authors: wong a, wong f. Antivir Ther. 2019;24(1):35-44. doi: 10.3851/IMP3278. Antivir Ther. 2019. PMID: 30382942

4

Previous incarceration impacts access to hepatitis C virus (HCV) treatment among HIV-HCV co-infected patients in Canada.

Kronfli N, Nitulescu R, Cox J, Moodie EE, Wong A, Cooper C, Gill J, Walmsley S, Martel-Laferrière V, Hull MW, Klein MB; Canadian Co-Infection Cohort Study. Kronfli N, et al. Among authors: wong a. J Int AIDS Soc. 2018 Nov;21(11):e25197. doi: 10.1002/jia2.25197. J Int AIDS Soc. 2018. PMID: 30460791 Free PMC article.

5

Variation in hepatitis C virus treatment uptake between Canadian centres in the era of direct-acting antivirals.

Nitulescu R, Young J, Saeed S, Cooper C, Cox J, Martel-Laferriere V, Hull M, Walmsley S, Tyndall M, Wong A, Klein MB; Canadian Co-Infection Cohort Study. Nitulescu R, et al. Among authors: wong a. Int J Drug Policy. 2019 Mar;65:41-49. doi: 10.1016/j.drugpo.2018.08.012. Epub 2018 Dec 26. Int J Drug Policy. 2019. PMID: 30594080

6

Epidemiologic and clinical features of chronic hepatitis B virus infection in 8 Canadian provinces: a descriptive study by the Canadian HBV Network.

Coffin CS, Ramji A, Cooper CL, Miles D, Doucette KE, Wong P, Tam E, Wong DK, Wong A, Ukabam S, Bailey RJ, Tsoi K, Conway B, Barrett L, Michalak TI, Congly SE, Minuk G, Kaita K, Kelly E, Ko HH, Janssen HLA, Uhanova J, Lethebe BC, Haylock-Jacobs S, Ma MM, Osiowy C, Fung SK; Canadian HBV Network. Coffin CS, et al. Among authors: wong p, wong a, wong dk. CMAJ Open. 2019 Oct 22;7(4):E610-E617. doi: 10.9778/cmajo.20190103. Print 2019 Oct-Dec. CMAJ Open. 2019. PMID: 31641059 Free PMC article.

7

Hepatitis C virus infection characteristics and treatment outcomes in Canadian immigrants.

Cooper CL, Read D, Vachon ML, Conway B, Wong A, Ramji A, Borgia S, Tam E, Barrett L, Smyth D, Feld JJ, Lee S; CANUHC Cohort. Cooper CL, et al. Among authors: wong a. BMC Public Health. 2020 Sep 3;20(1):1345. doi: 10.1186/s12889-020-09464-0. BMC Public Health. 2020. PMID: 32883249 Free PMC article.

8

Distinct Hepatitis B and HIV co-infected populations in Canada.

Cooper C, Driedger M, Wong D, Haylock-Jacobs S, Aziz Shaheen A, Osiowy C, Fung S, Doucette K, Wong A, Barrett L, Conway B, Ramji A, Minuk G, Sebastiani G, Wong P, Coffin CS. Cooper C, et al. Among authors: wong p, wong a, wong d. J Viral Hepat. 2021 Mar;28(3):517-527. doi: 10.1111/jvh.13453. Epub 2021 Jan 2. J Viral Hepat. 2021. PMID: 33306853

9

Salvage Therapy with Sofosbuvir/Velpatasvir/Voxilaprevir in DAA-experienced Patients: Results from a Prospective Canadian Registry.

Onofrio FQ, Cooper C, Borgia SM, Vachon ML, Ramji A, Lilly LB, Wong A, Booth J, Sattar I, Morales H, Lee S, Conway B, Feld JJ. Onofrio FQ, et al. Among authors: wong a. Clin Infect Dis. 2021 Jun 1;72(11):e799-e805. doi: 10.1093/cid/ciaa1510. Clin Infect Dis. 2021. PMID: 33677545

10

Effectiveness and Renal Safety of Tenofovir Alafenamide Fumarate among Chronic Hepatitis B Patients: Real-World Study.

Farag MS, Fung S, Tam E, Doucette K, Wong A, Ramji A, Conway B, Cooper C, Tsoi K, Wong P, Sebastiani G, Brahmania M, Haylock-Jacobs S, Coffin CS, Hansen BE, Janssen HLA. Farag MS, et al. Among authors: wong p, wong a. J Viral Hepat. 2021 Jun;28(6):942-950. doi: 10.1111/jvh.13500. Epub 2021 Apr 1. J Viral Hepat. 2021. PMID: 33749086

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,668 results

Search Page

Filters